Title

Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
A Randomized Clinical Trial Comparing Computer-assisted Cognitive Rehabilitation (CACR), Psycho-stimulants, and Placebo CACR in the Treatment of Attention Deficit/ Hyperactivity Disorder
  • Phase

    Phase 3
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    methylphenidate ...
  • Study Participants

    34
Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation (CACR), stimulant drugs and Placebo CACR on executive functions and clinical symptoms of children with attention deficit/hyperactivity disorder (ADHD).
The investigators administered a randomized controlled trial (RCT) through random assignment of ADHD subjects in to three different groups to compare the effects of CACR, immediate-release methylphenidate, and a Placebo CACR (i.e. some computerized tasks assumed not having any therapeutic effects) on the functioning of children with ADHD.
Study Started
Nov 30
2011
Primary Completion
Apr 30
2012
Study Completion
May 31
2012
Last Update
Apr 06
2015
Estimate

Other Computerized cognitive rehabilitation

- Computerized cognitive rehabilitation: 20 ninety-minute sessions of computerized cognitive rehabilitation.

Drug Ritalin

-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.

  • Other names: Immediate release methylphenidate

Other Placebo CACR [PCACR]

PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.

Computerized cognitive rehabilitation Experimental

-Computer-assisted cognitive rehabilitation (CACR): 20 Ninety-minute sessions of CACR.

Placebo CACR [PCACR] Placebo Comparator

-PCACR group simultaneously received 20 Ninety-minute sessions of Placebo CACR.

Ritalin Experimental

-2 to 3 doses of 10 mg Ritalin tablets per day during two months.

Criteria

Inclusion Criteria:

ADHD diagnosis
age between 7 and 12
IQ > 85

Exclusion Criteria:

sever co-morbid disorder
seizure
IQ < 85
disability
sever medical condition
No Results Posted